eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | metabolic syndrome x |
| Symptom | |hypertension |
| Sentences | 113 |
| PubMedID- 22934054 | On the other hand, increased adipose tissue mass is associated with insulin resistance, systemic dyslipidemia, hyperglycemia, hypertension, and components of the metabolic syndrome (dandona et al., 2005; despres, 2006). |
| PubMedID- 25659889 | Peripheral insulin resistance is a key component of metabolic syndrome associated with obesity, dyslipidemia, hypertension, and type 2 diabetes. |
| PubMedID- 24048967 | Also glucose intolerance and hypertension, both part of the metabolic syndrome, were evident in the gc-treated mice. |
| PubMedID- 20233452 | All the risk factors in our study, including overweight (obesity), dyslipidaemias and hypertension are components of the metabolic syndrome and insulin resistance. |
| PubMedID- 22304322 | Features of treatment of hypertension in patients with metabolic syndrome. |
| PubMedID- 21773016 | In addition, there is mounting evidence that chronic psychological stress and negative mood states are strongly associated, in a bidirectional manner, with insulin resistance, glucose intolerance, central obesity, dyslipidemia, hypertension, and other components of the metabolic syndrome . |
| PubMedID- 23757400 | Shrs are a model of human essential hypertension with features of metabolic syndrome, including impaired glucose metabolism. |
| PubMedID- 25646773 | Nafld refers to a spectrum of hepatic disorders secondary to an increase in hepatic triglyceride (tg) content in the setting of the metabolic syndrome that is associated with obesity, hypertension, hyperlipidemia and type ii diabetes 2. |
| PubMedID- 22030814 | This monosaccharide is linked to metabolic syndrome, being associated with hypertriglyceridemia, hypertension, insulin resistance and diabetes mellitus. |
| PubMedID- 20176994 | Obese persons with metabolic syndrome often have associated with salt-sensitive hypertension, microalbuminuria, and cardiac dysfunction, and the plasma aldosterone level in one-third of metabolic syndrome patients is clearly elevated. |
| PubMedID- 22728908 | Objectives: renin-angiotensin system inhibitors are preferred for the treatment of hypertension with metabolic syndrome (mets). |
| PubMedID- 24288531 | Sympathetic nervous system overactivity is a key mechanism leading to hypertension in patients with the metabolic syndrome. |
| PubMedID- 22294071 | Exploratory studies in patients with resistant hypertension and a variety of comorbidities, including insulin resistance/metabolic syndrome, obstructive sleep apnea and the polycystic ovary syndrome, have shown benefit of renal denervation in attenuating the severity of the comorbid conditions, as well as reducing bp. |
| PubMedID- 24122442 | Pm should be a priority for personslikely to have a blunted nighttime bp decline and elevated cvd risk, i.e., those who are elderly and obese, those with secondary or resistant hypertension, andthose diagnosed with diabetes, ckd, metabolic syndrome, and sleep disorders.de vigo, vigo, pontevedra, espana. |
| PubMedID- 21644841 | Methods: metabolic syndrome patients with hypertension (n=28) and a control group (n=20) were given atenolol (50 mg/day) for 4 weeks. |
| PubMedID- 23835112 | Sixty-six african-american subjects with stage 1 and 2 hypertension and characteristics of the metabolic syndrome were treated in open-label, active comparator fashion for 20 weeks. |
| PubMedID- 25159084 | Very often, obstructive sleep apnea (osa) and metabolic syndrome (ms) coexist with resistant hypertension (rhtn) and may lead to diastolic dysfunction. |
| PubMedID- 24417059 | Clinical features of arterial hypertension in patients with metabolic syndrome are described with reference to antihypertensive therapy and the choice of adequate drugs for the purpose. |
| PubMedID- 23974905 | Our results provide novel insight into the potential clinical value of rd in the treatment of hypertension with metabolic syndrome. |
| PubMedID- 20795419 | metabolic syndrome in patients with hypertension attending a family practice clinic in jordan. |
| PubMedID- 24466463 | hypertension is a component of metabolic syndrome, and interestingly, certain aldh2 genotypes have also been proposed as risk factors for metabolic syndrome with liver dysfunction 5. |
| PubMedID- 23808212 | The article is concerned with modern methods of assessment of arterial hypertension in patients with metabolic syndrome and characteristics of modern antihypertensive drugs and its combinations necessary for the elderly. |
| PubMedID- 22846983 | Targeting hypertension in patients with cardiorenal metabolic syndrome. |
| PubMedID- 23629805 | Thus, shrcp are regarded as a useful model of human hypertension with metabolic syndrome. |
| PubMedID- 25875942 | Non-alcoholic fatty liver disease (nafld) is the most common cause of hepatic disease in western civilization . |
| PubMedID- 24410986 | All components of metabolic syndrome, including hypertension , insulin resistance(ir) , and low hdl-c, together with high levels of tg are frequent in patients with osas. |
| PubMedID- 25760026 | Metabolic detuning has been reported to be involved in obesity, dyslipidemia, diabetesmellitus, and hypertension, all of which characterize metabolic syndrome and are closelyassociated with insulin resistance. |
| PubMedID- 25615826 | Medical costs for people with obesity are approximately 30% greater than for people with normal weights, because obesity is related to serious health problems such as diabetes, hypertension, and other components of metabolic syndrome 3. |
| PubMedID- 25508240 | Material and methods: we conducted an 8-week open prospective study on 36 patients with essential stage ii hypertension associated with metabolic syndrome. |
| PubMedID- 24958506 | Role of nitric oxide synthase uncoupling at rostral ventrolateral medulla in redox-sensitive hypertension associated with metabolic syndrome. |
| PubMedID- 26447765 | hypertension, one diagnostic criterion of metabolic syndrome, is regulated by the renin-angiotensin system 8 and angiotensin ii (angii) is important as a target of antihypertensive drugs. |
| PubMedID- 22555437 | Comprehensive studies, ranging from in vitro, in vivo, preclinical, to human, all suggest that attenuation of gc signaling, through 11β-hsd1 inhibition in metabolically important tissue such as the liver, is a therapeutically achievable strategy to ameliorate the glucose intolerance, obesity, fatty liver, and hypertension associated with metabolic syndrome. |
| PubMedID- 22305998 | A subgroup analysis in patients with hypertension and comorbidities of diabetes, cardiometabolic syndrome, or obesity, and in black participants is reported. |
| PubMedID- 20609696 | These agents may expand the utility of beta-blockers to patient populations traditionally considered not to be optimal candidates for beta-blocker therapy-a fact which has important clinical implications, because more antihypertensive agents are needed to diversify the therapeutic options available for clinicians treating hypertension in patients with the cardiometabolic syndrome or type 2 diabetes. |
| PubMedID- 22350229 | Obesity, dyslipidemia, type 2 diabetes, hypertension, and other components of metabolic syndrome actively correlate with development of nonalcoholic fatty liver disease (nafld) and hepatic insulin resistance and inadequate diabetes resolution after rygb . |
| PubMedID- 21500444 | Conclusions: in patients with isolated systolic hypertension, the association of the metabolic syndrome is the main cardiovascular risk and is associated with increase of diastolic blood pressure, presence of left ventricular hypertrophy and increased hypertensive load values. |
| PubMedID- 21925996 | The renin-angiotensin system (ras) is a common link between hypertension and comorbidities of obesity and metabolic syndrome (mets). |
| PubMedID- PMC3113071 | Hyperglycemia, insulin resistance, hyperlipidemia and hypertension, which are components of metabolic syndrome, are also recognized as strong risk factors for cardiovascular disease 1. |
| PubMedID- 19626043 | This study was designed to separate minerals and fiber from other components of dash on blood pressure in abdominally obese metabolic syndrome subjects with prehypertension to stage 1 hypertension (obese hypertensives). |
| PubMedID- 20921214 | Whether this association holds true in primary hypertension and is independent of renal function and metabolic syndrome is not clear at present. |
| PubMedID- 24386118 | Our present analyses, however, showed no association between ser23 c with bmi, dyslipidemia, or hypertension, three correlates of metabolic syndrome. |
| PubMedID- 22448351 | Pecularities of prolonged use of moxonidine in patients with hypertension associated with metabolic syndrome. |
| PubMedID- 25999772 | Previous literature has also hypothesized that white coat hypertension is associated with metabolic syndrome.25 metabolic syndrome is defined as an elevated risk for cardiovascular disease and diabetes. |
| PubMedID- 25383490 | Impaired fasting blood glucose is one of the landmark signs of metabolic syndrome, together with hyperinsulinemia, dyslipidemia, hypertension, and a chronic proinflammatory, pro-oxidative, and prothrombotic environment. |
| PubMedID- 22470194 | Nafld is usually part of the metabolic syndrome, found namely in patients with diabetes mellitus, hypertension, dyslipidemia, obesity and insulin resistance, which is becoming very frequent in western populations, due to their life style (sedentariness) and diet. |
| PubMedID- 20880339 | Although traditional anti-diabetes agents improve hyperglycaemia, they do so at a cost, which may entail hypoglycemia and increased body weight; exacerbating dyslipidemia, hypertension and components of insulin resistance and metabolic syndrome associated with t2dm-potentially increasing cardiovascular risk. |
| PubMedID- 25354240 | Thus, preserved stimulation of proximal tubule transport through the insulin/irs2/pi3-k pathway may play an important role in the pathogenesis of hypertension associated with metabolic syndrome. |
| PubMedID- 22988490 | Diabetes, obesity, and metabolic syndrome may lead to pulmonary hypertension through a mechanism involving hyperuricemia. |
| PubMedID- 25245490 | However, it appears to be a risk factor for early onset hypertension in metabolic syndrome. |
| PubMedID- 24843633 | Diabetic patients are often obese, which is frequently complicated by metabolic syndrome with hypertension or dyslipidemia26. |